long half-life and large variability [Regulatives / Guidelines]

posted by dshah – India, 2020-08-10 06:18 (354 d 03:52 ago) – Posting: # 21846
Views: 1,568

Hi All!

I believe there are few MR drug with high variability and still USFDA recommends partial or fully replicate design. Mesalamine PSG or
Mesalamine PSG for 800 mg strength
Considering the Mechanism of Action, PK variability, non-Linearity- the study and formultion could indeed be challenging.

Regards,
Dshah

Complete thread:

Activity
 Admin contact
21,592 posts in 4,514 threads, 1,532 registered users;
online 9 (0 registered, 9 guests [including 4 identified bots]).
Forum time: Friday 10:10 CEST (Europe/Vienna)

It is a capital mistake to theorise before one has data.    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5